Clinical Trial Update: Oral Contraceptive Interaction Study for GW273225 [Phase 1]

View source ↗

Summary

Phase 1 oral contraceptive interaction study of GW273225 in bipolar disorder patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• GW273225

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Phase 1 | Status: TERMINATED